Disclosure Of Entity's Operating Segments [Text Block]

Redcare Pharmacy N.V. - Filing #5831390

Concept 2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
2023-12-31 to
2024-12-31
As at
2024-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
As at
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
2022-12-31 to
2023-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
2,370,575,000 EUR
1,798,758,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
415,000 EUR
226,000 EUR
Tax expense (income)
1,477,000 EUR
2,742,000 EUR
Profit (loss) before tax
47,833,000 EUR
14,348,000 EUR
Profit (loss)
46,356,000 EUR
0 EUR
45,464,000 EUR
0 EUR
45,464,000 EUR
892,000 EUR
0 EUR
0 EUR
0 EUR
0 EUR
0 EUR
11,606,000 EUR
12,041,000 EUR
12,041,000 EUR
435,000 EUR
0 EUR
0 EUR
0 EUR
Assets
1,003,284,000 EUR
1,021,596,000 EUR
Cash flows from (used in) operating activities
22,126,000 EUR
61,456,000 EUR
Cash flows from (used in) investing activities
8,381,000 EUR
59,963,000 EUR
Cash flows from (used in) financing activities
17,936,000 EUR
15,046,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.